A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet's disease.

Behcet’s disease (BD) is a multi-organ inflammatory disorder characterized by oral aphthae, uveitis, erythema nodosum, and genital ulcers. Intestinal BD is a specific type of BD with typical volcan...